Cite

HARVARD Citation

    Kleemann, J. et al. (2018). Dropped‐head syndrome in a patient under treatment with the MEK inhibitor trametinib for NRAS‐mutated metastatic melanoma. Clinical and experimental dermatology. pp. 195-196. [Online]. 
  
Back to record